Advanced search Help
Searching for terms: EXACT: "Global Research Collaboration for Infectious Disease Preparedness" in: publisher
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
Preparing for a Second Wave: Understanding Transmission and How to Stop COVID-19 [video]
The following topics are addressed in this video: "What are the key knowledge gaps that need to be solved?"; "Paradoxes in Transmission"; "Modes of Transmission"; "Potential Amplifications Settings or Populations"; "The Epidemiology of COVID-19 [coronavirus disease 2019] in children: implications for school settings"; "Superspreading of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2]"; "Non-Pharmaceutical Interventions"; "COVID-19 contact tracing in Korea"; and "Perspective on COVID19 Transmission from an Engineering & Risk Assessment Lens." The duration of this video is 3 hours, 3 minutes, and 8 seconds.
Global Research Collaboration for Infectious Disease Preparedness
2020-07-29
-
COVID Research Synergies Meeting - Panel Discussion [video]
This video contains the following: closing discussion on COVID-19 vaccines; closing discussion on therapeutics and COVID-19; closing discussion on social sciences research and COVID-19; and "Preparing for a Second Wave - Understanding Transmission and How to Stop COVID-19 [coronavirus disease 2019]." The duration of this video is 3 hours, 9 minutes, and 45 seconds.
Global Research Collaboration for Infectious Disease Preparedness
2020-07-23
-
COVID Research Synergies Meeting - Social Sciences Research in COVID-19 [video]
This video consists of rapporteur presentations about various social science issues in relation to the coronavirus pandemic. The duration of this video is 2 hours, 27 minutes, and 10 seconds.
Global Research Collaboration for Infectious Disease Preparedness
2020-07-21
-
COVID Research Synergies Meeting - Therapeutics [video]
"Setting the Scene: Perspectives on therapeutics research"; "COVID [coronavirus disease] Epidemic in Brazil"; "From treating viral infection to other therapeutic avenues: repurposing and new development"; "Antiviral treatment"; "Adaptive Platform Treatment Trial for Outpatients with COVID-19 [coronavirus disease 2019]"; "Effect pf favipiravir in reducing viral load in asymptomatic and mild COVID-19 patients"; "High performance computing for the screening of existing Drugs (and for novel treatments)"; "Pre-clinical development of new boradspectrum antivirals for inhalation"; "Frontiers in Translational Medicine: The Clinician-Scientist Perspective"; "GLOPID [Global Research Collaboration for Infectious Disease Preparedness]-R Research Synergies: Therapeutics"; "Plasma Convalescence Treatment of COVID-19 Patients in Indonesia"; "Safety and efficacy of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] antibodies"; "Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) ACTIV-4"; "Approaches for pre- and postexposure prophylaxis"; "Unitaid's Contribution to the COVID-19 Global Response"; "cross-cutting aspects of therapeutics research"; "PANDORA [Pan-African Network for Rapid Research, Response, Relief and Preparedness for Infectious Diseases Epidemics]: Value of Investing in Regional Preparedness Network"; "Barriers of multicentric research '- situation analysis of COVID-19 crisis'"; and "Good Participatory Practices in Emerging Pathogen Research." The duration of this video is 3 hours, 5 minutes, and 25 seconds.
Global Research Collaboration for Infectious Disease Preparedness
2020-07-17
-
COVID Research Synergies Meeting - Vaccines [video]
The following topics are addressed in the video: "Setting the Scene: Perspectives on the COVID-19 [coronavirus disease 2019] Vaccine Landscape"; "COVID-19 Vaccine Development: Animal Models"; "COVID-19 Vaccine Development: Immunogenicity"; "COVID-19 Vaccine Development and Long-term Immune Memory"; "Vaccine Safety & Correlates of Protection"; "COVID-19 Vaccine Manufacturing in a Global Pandemic"; "Vaccine know-how as a global public good"; "Manufacturing, Implementation and Access"; "COVID-19 Vaccine Development: Considerations for Efficacy Endpoints"; "COVID-19 Vaccine Development: Requirements for Clinical Trial Sites and Regulatory Considerations in LMICs [low and middle-income countries]"; "Setting up a COVID-19 Vaccine Clinical Trial in South Africa: Speaking from Experience"; and "Clinical Trials and Regulatory Considerations." The duration of this video is 3 hours, 8 minutes, and 25 seconds.
Global Research Collaboration for Infectious Disease Preparedness
2020-07-16
-
GloPID-R and PREPARE Reaching Out: A Meeting to Advance Clinical Research Preparedness for Infectious Disease Outbreaks - Report of Proceedings and Key Outcomes
"This year marks the centenary of the 1918 Influenza pandemic: a stark reminder of our global vulnerability to infectious disease (ID) outbreaks. Features of modern day life such as urbanisation, changes in land use, climate change, and an increase in global travel and trade, have rendered epidemics and pandemics inevitable, particularly when considered alongside the burgeoning threat of antimicrobial resistance (AMR) . For many emerging infectious diseases, effective diagnostics, medications and vaccines are simply not available. Where these medical counter measures are available, the evidence for their use in specific ID outbreaks is often limited. [...] This meeting sought to 'reach out' to the different networks and stakeholders working on ID outbreak preparedness to explore, collaborate, and closely consider the PEARLES [political, ethical, administrative, regulatory, logistic, economic, and social] factors shaping preparedness research in order to advance our capacity to deliver clinical research as a core part of outbreak response."
Global Research Collaboration for Infectious Disease Preparedness; Platform for European Preparedness Against (Re-)emerging Epidemics
2018-11-12
1
